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Background: A 10% cocoa-enriched diet influences the immune system functionality including the 2 
prevention of the antibody response and the induction of lower immunoglobulin concentrations. 3 
However, neither cocoa polyphenols nor cocoa fiber can totally explain these immunoregulatory 4 
properties.  5 
Objective: This study aimed to establish the influence of cocoa theobromine in systemic and intestinal 6 
immunoglobulin concentrations and to determine the effect of cocoa or theobromine feeding on 7 
lymphoid tissue lymphocyte composition. 8 
Methods: Three-week-old female Lewis rats received either a standard diet (AIN-93M, RF group), a 9 
10% cocoa diet (CC group) or a 0.25% theobromine diet (the same amount provided by the CC diet, 10 
TB group) in 2 separated experiments lasting 19 (Experiment 1) or 8 days (Experiment 2). Serum IgG, 11 
IgM, IgA and intestinal secretory IgA (sIgA) concentrations were determined. In addition, at the end 12 
of Experiment 2, thymus, mesenteric lymph nodes (MLN) and spleen lymphocyte populations were 13 
analyzed. 14 
Results: Both CC and TB groups in Experiments 1 and 2 showed similar serum IgG, IgM and IgA and 15 
intestinal sIgA concentrations that were lower than those in the RF group (46-98% lower in 16 
Experiment 1 and 23-91% lower in Experiment 2) (p<0.05). In addition, in Experiment 2, the CC and 17 
TB diets similarly changed the thymocyte composition by increasing CD4-CD8- (+133%) and 18 
CD4+CD8- (+53%) proportions (p<0.01), MLN composition by decreasing the percentage of Th 19 
lymphocytes (-3%) (p=0.015) and spleen composition by increasing the proportion of Th lymphocytes 20 
(+9%) (p<0.001) after 1 week of diet treatment.  21 
Conclusions: The theobromine in cocoa plays an immunoregulatory role that is responsible for 22 
cocoa’s influence on both systemic and intestinal antibody concentrations and also for modifying 23 
lymphoid tissue lymphocyte composition in young healthy Lewis rats. The majority of these changes 24 
are observed after a single week of consuming a diet containing 0.25% theobromine.  25 
Keywords: cocoa, immune system, immunoglobulins, lymphoid tissues, mesenteric lymph node, 26 
methylxanthine, spleen, theobromine, thymus27 
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1. Introduction 28 
Cocoa, derived from Theobroma cacao fermented seeds, was introduced by the Mayan and Aztec 29 
civilizations as dietary and medicinal food and was diffused to Europe in the mid-1500s (1). At 30 
present, cocoa products are consumed worldwide (2), mainly as a snack due to its pleasurable taste. 31 
Furthermore, an increasing number of health properties have been attributed to its consumption, such 32 
as promoting cardiovascular health, preventing metabolic and endocrine disorders and improving 33 
cognition, mood and behavior (2–7).  34 
In previous studies, we extensively reported that the feeding of a cocoa-enriched diet has an 35 
immunoregulatory effect on rats. Specifically, a diet containing 10% (w/w) cocoa in 3- or 6-week-old 36 
Wistar, Lewis or Brown-Norway rats influences systemic and intestinal immunoglobulin 37 
concentrations and lymphoid tissue composition (8–10). In particular, in the thymus, a cocoa diet 38 
increases the proportion of mature single positive CD4+CD8- cells and decreases the immature 39 
CD4+CD8+ cells (8). In mesenteric lymph nodes (MLN), cocoa intake increases the proportion of 40 
TCRγδ+ cells and Tc cells (9), whereas in the spleen, this nutritional intervention induces a higher 41 
percentage of B cells together with a reduction in the Th lymphocyte proportion (10). With regard to 42 
immunoglobulins, a diet containing 10% (w/w) cocoa to six-week-old female Wistar rats for three 43 
weeks decreases the concentration of serum IgG2a and IgM and secretory IgA (sIgA) and secretory 44 
IgM (sIgM) (11). Similar results were observed after two weeks of cocoa diet in eight-week-old male 45 
Lewis rats feeding different cocoa flavonoid-enriched diets with a flavonoid content ranging between 46 
0.2 and 0.8% (w/w) (12). In this vein, the immunoregulatory influence of cocoa has been used to 47 
prevent the development of both allergy and oral sensitization in rat models, in which it has effectively 48 
prevented specific antibody synthesis (13–15). 49 
Cocoa contains carbohydrates, proteins, lipids, fiber, minerals, polyphenols and methylxanthines (16). 50 
Among polyphenols, flavonoids are the most important and include procyanidins, epicatechin and 51 
catechin. Over the last decades, a great number of cocoa benefits have been described as a result of the 52 
antioxidant and anti-inflammatory properties of these polyphenols (2,17–19). However, cocoa is also a 53 
source of methylxanthines. These compounds are derived from xanthines and are found in several 54 
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vegetal derivatives (20), such as coffee, tea and cocoa, which contain caffeine, theophylline and 55 
theobromine as the most relevant methylxanthines, respectively (21). Cocoa contains both 56 
theobromine and caffeine, the first being the most abundant (22). Currently, several theobromine 57 
health effects have been described. In this context, among other physiological effects, theobromine 58 
acts on oral health, suppresses cough, produces bronchodilation in asthma patients, and inhibits acid 59 
uric crystallization (22–25). Today, there is increasing evidence regarding the important role played by 60 
this methylxanthine in the healthy properties of cocoa (22,23). Theobromine effects can be related to 61 
its action in the inhibition of the adenosine receptor, phosphodiesterases and/or poly(ADP-ribose) 62 
polymerase-1 (22). As the latter enzyme has many actions on the immune system, such as promoting 63 
inflammatory response affecting both innate and adaptive immune response (26), it is plausible that its 64 
inhibition could be responsible for cocoa’s immunoregulatory effect. 65 
In recent years, interest in the identification of those cocoa compounds that play an immunoregulatory 66 
role has grown. For that reason, several experimental designs have been carried out in order to 67 
ascertain whether polyphenols or cocoa fiber are responsible for the immunomodulatory properties of 68 
cocoa. Nevertheless, in both cases, the results showed that these components only partially explained 69 
the impact of cocoa on the immune system and, therefore, other cocoa compounds might contribute to 70 
the attenuation of the humoral immune response (12,27,28). In fact, the effect of theobromine on the 71 
immune system is not yet known. On the basis of these previous studies, we aimed to establish the 72 
influence of cocoa theobromine in systemic and intestinal immunoglobulin concentrations and to 73 
determine the effect of one week of cocoa or theobromine feeding on lymphoid tissue lymphocyte 74 
composition. 75 
2. Methods  76 
2.1. Animals and experimental nutritional intervention  77 
Two separate experiments, Experiment 1 and Experiment 2, were carried out differing only in length. 78 
In both cases, three-week-old female Lewis rats obtained from Janvier Labs (Saint Berthevin Cedex, 79 
France) were housed (2–3 rats/cage) under controlled conditions of temperature and humidity in a 12 h 80 
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/ 12 h light/dark cycle. In both experiments, the rats were randomly assigned into three dietary groups 81 
(n = 6–7 each): the reference (RF) group, fed with the standard diet AIN-93M (Harlan Laboratories 82 
Inc., Madison, WI); the cocoa (CC) group, fed a 10% (w/w) cocoa diet; and the theobromine (TB) 83 
group fed a standard diet with 0.25% (w/w) theobromine, which was the same amount provided by the 84 
10% cocoa diet (Supplemental Table 1). The food containing 10% cocoa was kept isoenergetic by 85 
extracting to a basal mix the amount of protein, lipid, carbohydrate, fiber, mineral and vitamins 86 
provided by 10% cocoa. Therefore, the addition of cocoa to the basal mix has the same amount of 87 
macronutrients and micronutrients as AIN-93M diet, providing about 7.6% of the total energy 88 
provided by the diet (3.8 kcal/g). Animals were given free access to water and food. Experiment 1 89 
lasted 19 days and Experiment 2 lasted 8 days. All the experimental procedures were performed 90 
according to the Guide for the Care and Use of Laboratory Animals, reviewed and approved by the 91 
Ethical Committee for Animal Experimentation of the University of Barcelona (CEEA/UB ref. 5988). 92 
2.2. Sample collection and processing 93 
Blood and fecal samples were collected throughout the Experiment 1 (feces on days 0, 8 and 19 and 94 
blood on day 19) and 2 (feces on days 0, 4 and 8 and blood on days 4 and 8). Serum was kept at -20°C 95 
until immunoglobulin (IgG, IgG isotypes, IgM and IgA) quantification. Fecal samples were collected 96 
and treated as in previous studies in order to obtain fecal homogenates (20 mg/mL), which were kept 97 
at -20°C until sIgA quantification (30).  98 
At the end of Experiment 2, on day 8, the animals were euthanized and the thymus, MLN and spleen 99 
were carefully removed. Thymus and spleen were immediately weighed. For lymphocyte isolation, 100 
tissue samples were passed through a sterile mesh cell strainer (40 µm, ThermoFisher Scientific) and 101 
the resultant cell suspensions were used for thymus and MLN samples, whereas spleen samples were 102 
submitted to the osmotic lyses of erythrocytes as previously described (10). Cell counting and viability 103 
were determined by a CountessTM Automated Cell Counter (Invitrogen™, Thermo Fisher Scientific). 104 
2.3. Immunoglobulin determination 105 
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Serum IgG, IgG1, IgG2a, IgG2b, IgG2c, IgM, IgA and intestinal sIgA concentrations were quantified 106 
by a sandwich enzyme-linked immunosorbent assay (ELISA) from Bethyl Laboratories (Montgomery, 107 
TX, USA), following the manufacturer’s instructions. Absorbance was measured at 492 nm by a 108 
photometer (Labsystems Multiskan, Helsinki, Finland) and data were interpolated with Multiskan 109 
Ascent v.2.6 software (Thermo Fisher Scientific S.L.U, Barcelona, Spain) according to the 110 
concentration of the corresponding standards. 111 
2.4. Assessment of lymphocyte composition by flow cytometry analysis 112 
Lymphocytes from thymus, MLN and spleen were stained with the mouse anti-rat CD4, CD8α, CD8β, 113 
TCRαβ, TCRγδ, NKR-P1A (BD Biosciences, Oxford, UK) and CD62L (Biolegend, San Diego, CA, 114 
USA) monoclonal antibodies conjugated to fluorescein isothiocyanate (FITC), phycoerythrin (PE), 115 
peridinin-chlorophyll-protein (PerCP) or allophycocyanin (APC), as previously described (14). All 116 
results were assessed by the Flowjo v.10 software (Tree Star Inc., Ashland, OR, USA). 117 
2.5. Statistical analysis 118 
For the statistical analysis, results were evaluated with the software package SPSS 22.0 (IBM 119 
Statistical Package for the Social Sciences, version 22.0, Chicago, IL, USA). Data from the 3 groups 120 
were compared to one. The Levene test was performed to assess the homogeneity of variance 121 
(homoscedasticity) of the results, and the Shapiro–Wilk test to assess their distribution. Homogeneity 122 
of variance and normal distributed data were analyzed by the parametric test one-way ANOVA 123 
followed by Bonferroni’s post hoc test. Body weight values and immunoglobulins concentrations 124 
studied at different time points were evaluated by repeated measures ANOVA. Significant differences 125 
were established when p ≤ 0.05. 126 
In contrast, the results having different variance and/or different distribution (IgG isotype 127 
concentrations) were evaluated by the Kruskal–Wallis and Mann–Whitney U nonparametric tests. 128 
These results were represented using Whisker plots. 129 
  130 
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3. Results 131 
3.1. Effect of cocoa theobromine on serum immunoglobulins 132 
At the end of Experiment 1, after 19 days of consuming the CC or TB diet, the concentration of IgG, 133 
was similar in the CC and TB groups and it was lower than that in the RF group (p<0.001) (Figure 134 
1A). However, no differences between groups were seen earlier (Figure 1B). The lower total IgG 135 
concentration on day 19 was mainly due to lower levels of IgG1, IgG2b and IgG2c isotypes (p≤0.050) 136 
(Figure 1A–B and Supplemental Figure 1).  137 
Total serum IgM and IgA in Experiment 1 were also lower (p<0.001) after CC and TB interventions 138 
(Figure 1C–D). The analysis in the Experiment 2  revealed that IgM and IgA levels in CC and TB 139 
group were already lower than those in the RF group at days 4 and 8, respectively (p≤0.005 and 140 
p≤0.003, respectively) (Figure 1E–F).  141 
3.2. Effect of cocoa theobromine on intestinal sIgA  142 
In order to ascertain the contribution of the theobromine in cocoa in the intestinal compartment, sIgA 143 
was also quantified in feces samples throughout both experiments (Figure 2). RF group showed an 144 
increased pattern in intestinal IgA content associated with age (p<0.001). This increase did not occur 145 
in the CC and TB groups which had similar concentrations of intestinal sIgA that were lower than 146 
those present in RF group (p<0.001). The difference was already detectable after 4 days of CC or TB 147 
intake (p≤0.003) (Figure 2B). 148 
3.3. Effect of cocoa theobromine on thymus, MLN and spleen 149 
In the Experiment 2, the three groups had similar body weight at the beginning of the study (Table 1). 150 
At the end of the study, after 1 week of diet, the CC and TB groups had higher body weight than that 151 
observed at the beginning (p<0.001) but the increase was lower than that of the RF group (p<0.001) 152 
although no differences were detected in the relative food intake between the three studied groups 153 
(Table 1). Moreover, the CC and TB groups had lower lymphoid tissues relative weights compared 154 
with the RF group after one week of diet (p≤0.005) (Table 1).  155 
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The phenotype of lymphocytes from thymus, MLN and spleen was studied after one week of the 156 
nutritional intervention (Experiment 2). Lymphocytes from thymus are classified into four subsets 157 
according to the expression of CD4 and CD8 molecules (Figure 3, Supplemental Figure 2). The 158 
most immature population are CD4-CD8- cells (double-negative or DN), then these cells turn into 159 
CD4+CD8+ cells (double-positive or DP) to finally become CD4-CD8+ or CD4+CD8-cells (single 160 
positive or SP), corresponding to the most mature thymocytes which eventually migrate to the 161 
peripheral lymphoid organs (31,32). Both CC and TB groups showed a higher relative amount of 162 
CD4-CD8- and CD4+CD8- cells than RF group (p<0.001 and p≤0.037, respectively), whereas 163 
CD4+CD8+ cell proportion was lower (p=0.001) (Figure 3A, Supplemental Figure 2). In addition, in 164 
the thymocyte maturation, there was a gradual increase in the expression of the antigenic receptor 165 
TCRαβ, TCRαβhigh being the most mature cells. A lower proportion of CD4-CD8-TCRαβhigh was 166 
observed in both nutritional interventions with respect to the RF group (p≤0.004) (Table 2). 167 
Otherwise, in CD4-CD8+ cells, the proportion of TCRαβhigh thymocytes in the CC and TB groups was 168 
higher than in the RF group (p≤0.001) whereas both that of TCRαβlow and TCRαβ- cells was lower 169 
(p≤0.034) (Table 2). With regard to the MLN, the proportions of the main lymphocyte subsets, e.g. 170 
CD45RA+ (B lymphocytes), TCRαβ+, TCRγδ+ and NK cells, were not modified in CC or TB groups 171 
(Figures 4A). However, both the CC and TB groups showed a lower proportion of TCRαβ+CD4+ 172 
(Th) lymphocytes (p≤0.027) and higher proportion of TCRαβ+CD8+ (Tc) cells (p≤0.016) than RF 173 
animals (Figure 4B). Consequently, Th/Tc ratio was similarly reduced after the CC or TB diets 174 
(p≤0.013) (Figure 4C). In the case of TCRγδ+ cells, no significant differences were observed as a 175 
result of the diets in either the CD8αα+ or CD8αβ+ subsets (Supplemental Figure 3). With regard to 176 
the proportion of those Th, Tc and B cells expressing CD62L (L-selectin), a different pattern was 177 
found after the cocoa-enriched diet only, which showed a reduced proportion of CD45RA+CD62L+ 178 
cells (p=0.040) and a higher proportion of CD45RA+CD62L- (p=0.040) (Figure 4D).  179 
The spleen was also affected after 8 days of either the CC or TB diet. In particular, after both 180 
interventions there was a lower proportion of TCRγδ+ and NK cells compared with that of the RF 181 
group (p≤0.038 and p<0.001, respectively) although no significant differences were found in TCRαβ+ 182 
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and CD45RA+ lymphocytes (Figures 5A). However, studying the TCRαβ+ subsets in depth, in 183 
contrast to what happened in the MLN, after both diets there was a higher proportion of Th cells than 184 
in the RF group (p<0.001), whereas there was a lower percentage of Tc and NKT cells (p≤0.043 and 185 
p<0.001, respectively) (Figure 5B). As a result, the Th/Tc ratio was significantly higher in the CC and 186 
TB groups than in the reference group (p≤0.013) (Figure 5C). The percentage of TCRγδ+CD8αα+ 187 
and TCRγδ+CD8αβ+ cells in the three groups was similar (Supplemental Figure 4A). In the case of 188 
the CD62L marker on CD4+, CD8+ and CD45RA+ cells, no differences were detected as a result of 189 
the nutritional interventions (Supplemental Figure 4B).  190 
4. Discussion  191 
Previous studies carried out in rats demonstrated that a 10% (w/w) cocoa diet has the potential to 192 
regulate the immune status, attenuating the antibody concentrations both in systemic and intestinal 193 
compartments (9–11,33,34), and modifying lymphoid tissue composition mainly in the gut-associated 194 
lymphoid tissue (GALT) (8–11). These effects could not be totally attributed to the cocoa polyphenol 195 
or fiber content (12,35,36). The present data show, for the first time, the role of theobromine in 196 
cocoa’s effects on antibody concentrations and on lymphoid tissues in young healthy rats. In addition, 197 
this study reveals the effects of cocoa and theobromine on lymphoid tissue after only one week of 198 
intervention. 199 
The current results demonstrate that the CC diet influences the circulating concentrations of 200 
immunoglobulins. Specifically, the rats fed the CC diet had lower IgG concentration than the RF 201 
group after 19 days of diet, in accordance with the previous reported effects of a 10% cocoa diet for 3 202 
weeks on 3-week-old Wistar rats (10,35), whereas it did not match with a study carried out in older 203 
animals, in particular in 8-week-old Lewis rats (12). These results reflect the importance of age in 204 
cocoa’s effects on IgG. The higher sensitivity in young rats could be due to the more immature 205 
immune system. Rats are born with an immature immune system that develops during suckling and 206 
that even at weaning time is not yet mature (37). Regarding the sensitivity of each IgG isotype 207 
(IgG2c>IgG2b>IgG1), previous studies modified them differently (11,27,34), reflecting that, among 208 
others, rat strain and environment could also be important in the influence of cocoa on IgG. 209 
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Nonetheless, it is worth noting that theobromine on its own produced an identical effect on serum IgG 210 
and its isotypes concentrations to that of cocoa. 211 
Likewise, TB and CC groups also showed similar lower concentrations of IgM and IgA with respect to 212 
RF group. These results partially or completely agree with those found after 3 or 7 weeks of 10% 213 
cocoa diet in 3-week-old or 6-week-old Wistar rats (10,11,34,35), and after 2 weeks of different 214 
cocoa-polyphenol-enriched diets in 8-week-old Lewis rats (12). In addition, the current data show that 215 
IgM was affected earlier than IgA and both immunoglobulins earlier than IgG. In any case, most 216 
importantly, we can conclude that theobromine is responsible for cocoa’s influence on systemic 217 
immunoglobulin concentrations. 218 
With respect to intestinal antibodies, sIgA content increased in young rats throughout the studied 219 
period as previously reported (30), and this increasing pattern was avoided by the cocoa diet as a result 220 
of its theobromine content. This down-regulatory effect was already observed after 4 days of the 221 
nutritional intervention and corresponded with prior data obtained after one (11,12), two (9,27), three 222 
(27,35), six (33) or seven weeks (34) of cocoa feeding using different rat strains. It is worth noting 223 
that, physiologically, IgA is the last antibody synthesized (38) and therefore, being the most immature, 224 
it could be the most sensitive to the immunoregulatory effect of the diet. On the other hand, changes in 225 
intestinal sIgA could be attributed to modifications in intestinal microbiota. In fact, both the CC and 226 
TB diets induced changes in the gut bacteria pattern (39,40) but these modifications differ between the 227 
two interventions. In consequence, this suggests that the microbiota changes might not be the primary 228 
determinant of the effect on sIgA concentrations.  229 
On the other hand, this study also focused on the effect of CC and TB diets on the lymphoid tissues. 230 
Previous studies have reported the influence of cocoa diet on MLN after at least 3 or 4 weeks of diet 231 
(9,14,41,42), whereas studies on the spleen and the thymus are very limited (8,10). Indeed, in none of 232 
the studied lymphoid organs are there any results regarding such a short diet period. First of all, it must 233 
be taken into consideration that after only one week of either CC or TB diet, body weight was lower 234 
than that in the RF group. This fact could be considered a limitation of the study, although the relative 235 
food consumption (calculated per 100 g body weight) did not change during the study as previously 236 
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reported (11,14). On the other hand, the relative weight of spleen and thymus from animals fed CC or 237 
TB was lower than that in rats fed the standard diet, suggesting that these compounds could, among 238 
other changes, inhibit the proliferation of lymphocytes, interfere with lymphocyte trafficking to 239 
lymphoid organs or increase the progressive thymus age-related regression (43) that will eventually 240 
reduce lymphoid tissue organ weight. Nevertheless, further studies are required to determine the exact 241 
impact of TB in such lymphoid organs. In addition, the study of the thymus composition revealed that, 242 
in comparison to the RF group, CC and TB intake resulted in a higher proportion of CD4-CD8- cells 243 
and CD4+CD8- lymphocytes, whereas there was a lower proportion of CD4+CD8+ cells. 244 
Furthermore, both nutritional interventions resulted in a lower expression of TCRαβ on CD4-CD8- 245 
cells. The relatively higher amount of the less mature cell type (CD4-CD8- cells) is in line with 246 
previous data obtained with a longer diet period (8). Further studies are required to ascertain whether 247 
TB either delays T cell maturation, reduces the arrival of cells and/or enhances the number of cells 248 
leaving the thymus. Nevertheless, these thymocyte proportion changes after 8 days of diet were not 249 
associated with a lower proportion of T cells in either MLN or spleen. However, longer intake studies 250 
have demonstrated a decrease in the proportion of TCRαβ+ cells in lymph nodes (14). These results 251 
suggest that the main effect of cocoa can be in T cell maturation in the thymus and, later, those 252 
modifications will be reflected in the lymph nodes.  253 
In the current study, in spite of the changes in the thymus populations, the balance of the main 254 
populations in the MLN and the spleen was not modified by the diet. These results do not agree with 255 
those found in the same tissues for a longer timer (10,14). Therefore, we suggest that these previously 256 
observed changes would need an extended cocoa intake. However, the current results in MLN showed 257 
a lower proportion of Th cells and a higher proportion of Tc cells after one week of CC or TB intake 258 
with respect to RF conditions, as found in longer studies (9,14), which could be due to changes in 259 
thymocyte maturation. Nevertheless, in the case of the spleen composition, there was a contrary effect, 260 
i.e. a higher proportion of Th cells and a lower Tc cell percentage. This could be due to the movement 261 
of Th cells in the thymus to the spleen.  262 
In the spleen, the CC and TB diets induced lower proportions of the TCRγδ+ and NK cells that did not 263 
agree with the reported effect in a longer study (10). On the other hand, in the current study, TCRγδ+ 264 
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cell and NK cell proportions in MLN were not modified by the nutritional interventions. However, 265 
other studies reported that cocoa-fed animals had a higher proportion of TCRγδ+ (and sometimes NK 266 
cells) in MLN (9,14), Peyer’s patches and intestinal intraepithelial lymphocytes (44), which could 267 
indicate that these cells leave the spleen to go to these peripheral lymphoid organs, although in terms 268 
of the MLN, our study was not long enough to demonstrate such an increase.  269 
The comparison of the effects of the CC and TB diets on the composition of both primary and 270 
secondary lymphoid tissues revealed that both diets produced the same degree of action in the 271 
modified lymphocyte subsets. Overall, these results indicate that theobromine is the main compound 272 
responsible for the immunoregulatory effect of cocoa on the lymphoid tissues, in addition to its 273 
previously stated effect on the attenuation of systemic and intestinal antibody concentrations. Until 274 
now, different effects of theobromine have been published, but, as far as we know, no previous results 275 
suggesting the role of theobromine as an immunoregulatory agent have been published. In this context, 276 
although the current study was carried out only in young healthy rats, the results suggest that 277 
theobromine has an immunoregulatory potential and could be indicated in some disorders, such as in 278 
organ transplantation to prevent rejection (45), in autoimmune disorders (multiple sclerosis, 279 
rheumatoid arthritis, systemic lupus erythematosus) (46) and in hypersensitivity reactions (allergic 280 
disease and asthma) (47). In particular, the previously reported tolerogenic effect of cocoa on food 281 
allergy and oral sensitization rat models (13–15,44) could be due to its theobromine content. 282 
Nevertheless, further studies must confirm the potential of theobromine as an immunoregulatory agent 283 
in pathological conditions. 284 
With regard to theobromine’s mechanism of action, it has been described as a potent inhibitor of the 285 
poly(ADP-ribose)polymerase-1 (PARP-1) (48). PARP-1 is a nuclear enzyme that has an essential role 286 
in DNA repair (48) and relevant immunological functions, including the regulation of gene 287 
transcription in dendritic cells, macrophages and lymphocytes (26). In this context, PARP-1 activation 288 
has been associated with pathologic conditions such as in inflammatory response in murine asthma 289 
models (49,50), and its inhibition prevents airway eosinophilia and suppresses Th2 cytokine 290 
production (51,52). It has also been reported that PARP-1 negatively regulates Treg cell function 291 
(53,54) and higher numbers of CD4+CD25+FoxP3+ Treg cells appear in thymus, spleen and lymph 292 
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nodes of PARP-1 knockout mice (55). Altogether, these facts lead us to think that the reported 293 
inhibition of PARP-1 by theobromine (48) could have an important implication in the 294 
immunoregulatory role described here. Nevertheless, further studies are required to establish the exact 295 
mechanisms and to ascertain the minimum dose required of this methylxanthine for it to be able to 296 
produce the observed effects. Moreover, clinical studies are needed in order to confirm such effects in 297 
humans and also to establish the optimal age and dose needed. Taking into consideration the Reagan-298 
Shaw formula (56), to achieve the immunoregulatory action of cocoa, a human with a body weight of 299 
60 kg, would have to eat more than one chocolate bar per day. Nevertheless, the current findings show 300 
that cocoa’s immunoregulatory effects can be achieved with theobromine alone which avoids such a 301 
high chocolate intake. In addition, it is worth noting that the effects of cocoa and theobromine are 302 
mainly observed after just one week of intake, which means that the immunoregulatory properties 303 
could be achieve with the acute intake of such compounds.  304 
In conclusion, a 10% cocoa-enriched diet, due to its theobromine content, is able to decrease systemic 305 
and intestinal immunoglobulin concentrations in young healthy Lewis rats and modify thymus, 306 
mesenteric lymph nodes and spleen lymphocyte composition after a single week of dietary 307 
intervention suggesting for the first time the role of theobromine as an immunosuppressive agent. 308 
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FIGURE 1. Serum IgG (A, B), IgM (C, D), and IgA (E, F) concentrations in Lewis rats fed a 
reference diet alone or including cocoa or theobromine for 19 (A, C, E; Experiment 1) or 8 (B, D, 
F; Experiment 2) days. Values are means ± SEMs, n=6-7. Labeled means in a panel without a 
common letter differ (p≤0.05) CC: cocoa group; NS: nonsignificant (P>0.05); RF: reference group; 




FIGURE 2. Intestinal sIgA concentrations in Lewis rats fed a reference diet alone or including 
cocoa or theobromine for 19 (A; Experiment 1) or 8 (B; Experiment 2) days. Values are means ± 
SEMs, n=6-7. Labeled means in a panel without a common letter differ (p≤0.05). CC: cocoa group; 





FIGURE 3. Percentage of thymocytes expressing or not CD4 and CD8 molecules in Lewis rats 
fed a reference diet alone or including cocoa or theobromine for 8 days (Experiment 2). Values 
are means ± SEMs, n=6. Labeled means in a subset without a common letter differ (p≤0.05). CC: 





FIGURE 4. Percentage of the main lymphocyte subsets (A) and TCRαβ+ subsets (B),  Th/Tc 
ratio (C), and proportion of CD62L+ and CD62L- cells either in CD4+, CD8+ or CD45RA+ 
lymphocytes (D) in mesenteric lymph nodes of Lewis rats fed a reference diet alone or including 
cocoa or theobromine for 8 days (Experiment 2). Values are means ± SEMs, n=6. Labeled means in 





FIGURE 5. Percentage of the main lymphocyte subsets (A) and TCRαβ+ subsets (B), and Th/Tc 
ratio (C) in spleen of Lewis rats fed a reference diet alone or including cocoa or theobromine for 
8 days (Experiment 2).Values are means ± SEMs, n=6. Labeled means in a subset without a common 






TABLE 1. Body weight, relative food intake and relative weight of thymus and spleen in Lewis 
rats fed a reference diet alone or including cocoa or theobromine for 8 days (Experiment 2)1.  
  Group2  
 RF CC TB 
Body weight, g    
Day 0 80.08 ± 2.25 79.98 ± 1.86 80.62 ± 2.17 
Day 8 115.38 ± 2.14*a 103.42 ± 1.82*b 103.65 ± 1.80*b 
Relative food intake, g/(100 g body x 8d) 60.31 ± 0.27 62.74 ± 0.83 58.32 ± 0.69 
Relative tissue weight, g/100 g body    
Thymus 0.39 ± 0.01a 0.22 ± 0.01b 0.20 ± 0.02b 
Spleen 0.30 ± 0.01a 0.24 ± 0.01b 0.25 ± 0.01b 
 
1 Values are means ± SEMs, n = 6. Labeled means in a row without a common superscript letter differ, 
p≤0.05.  
2 CC: cocoa group; RF: reference group; TB: theobromine group. 
* Different from day 0, p<0.001  
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TABLE 2.  Percentage of thymocytes according to the expression of TCRαβ (high, low or 
negative) molecule on each of the four subsets defined by CD4 and CD8 expression in Lewis rats 
fed a reference diet alone or including cocoa or theobromine for 8 days (Experiment 2)1. 
 Group2 
Thymocyte subset RF CC TB 
CD4-CD8-, %    
TCRαβlow 29.8 ± 3.7 25.5 ± 2.5 22.1 ± 1.6 
TCRαβhigh 14.7 ± 1.4a 6.2 ± 1.1b 8.4 ± 1.0b 
TCRαβ- 55.5 ± 3.6b 68.2 ± 3.7a 69.5 ± 2.1a 
CD4+CD8+, %    
TCRαβlow 81.0 ± 0.7 82.0 ± 0.8 81.0 ± 0.9 
TCRαβhigh 4.0 ± 0.2 3.9 ± 0.3 4.0 ± 0.2 
TCRαβ- 15.0 ± 0.7 14.1 ± 0.9 15.0 ± 1.0 
CD4-CD8+, %    
TCRαβlow 24.0 ± 2.5a 10.1 ± 1.5b 12.5 ± 1.5b 
TCRαβhigh 72.8 ± 2.7b 88.5 ± 1.5a 86.2 ± 1.8a 
TCRαβ- 3.0 ± 0.4a 1.5 ± 0.3b 1.4 ± 0.4b 
CD4+CD8-, %    
TCRαβlow 30.1 ± 1.8 30.5 ± 2.1 26.0 ± 2.6 
TCRαβhigh 59.5 ± 1.8 58.3 ± 2.7 63.4 ± 2.7 
TCRαβ- 10.3 ± 0.8 11.2 ± 1.1 10.7 ± 1.4 
 
1 Values are means ± SEMs, n = 6. Labeled means in a row without a common superscript letter differ, 
p≤0.05.  
2 CC: cocoa group; RF: reference group; TB: theobromine group.  
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Online Supporting Material 
Supplemental Table 1. Composition of the experimental diets fed to Lewis rats for 19-days or 
8-days.  
Components Diets 1, g/kg diet 
 
RF CC TB 
 
  Basal mix2 Cocoa powder3   
Carbohydrates 7224 6964 18 7204 
Proteins 1415 1175 23 1405 
Lipids 38.76 26.06 11.5 38.66 
Insoluble fiber 507 247 26 507 
Soluble fiber - - 8.5 - 
Minerals 35.98 27.18 6.1 35.88 
Vitamins 10.209 7.929 0.04 10.209 
Choline bitartrate 2.5 2.0 - 2.5 
Antioxidant (tert-
butylhydroquinone) 
0.01 0.01 - 0.01 
Theobromine - - 2.5 2.5 
Polyphenols - - 4 - 
Total 1000 1000 1000 
 
1 CC: cocoa diet; RF: reference diet (AIN-93M, Harlan Laboratories Inc., Madison, WI); TB: 
theobromine diet 
2 Harlan Laboratories Inc., Madison, WI 
3 The composition of cocoa has been previously reported  (29) 
4 Corn starch, maltodextrin and sucrose 
5 Casein and L-cysteine 
6 Soybean oil 
7 Cellulose 
8 AIN-93-MX (Harlan Laboratories Inc., Madison, WI)  
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Supplemental Figure 1: Serum IgG isotype concentrations in Lewis rats fed a reference diet 
alone or including cocoa or theobromine for 19 days (Experiment 1). Values are represented in a 
Whisker plot, n=6. Labeled means in an isotype without a common letter differ (p≤0.05). CC: cocoa 
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Supplemental Figure 2. Representative flow cytometry histograms of CD4/CD8 expression on 
thymocytes in Lewis rats fed a reference diet alone or including cocoa or theobromine for 8 days 
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Supplemental Figure 3. Percentage of TCRγδ+ subsets in mesenteric lymph nodes of Lewis rats 
fed a reference diet alone or including cocoa or theobromine for 8 days (Experiment 2). Values 
are means ± SEMs, n=6. No statistically significant results were detected. CC: cocoa group; RF: 





































Online Supporting Material 
Supplemental Figure 4. Percentage of TCRγδ+ subsets (A),  CD62L+ and CD62L- cells either in 
CD4+ lymphocytes (B), CD8+ lymphocytes (C) or CD45RA+ lymphocytes (D) in Lewis rats fed a 
reference diet alone or including cocoa or theobromine for 8 days (Experiment 2). Values are 
means ± SEMs, n=6. No statistically significant results were detected. CC: cocoa group; RF: reference 
group; TB: theobromine group. 
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